Author:
Asakura T,Sawai T,Hashidume Y,Ohkawa Y,Yokoyama S,Ohkawa K
Publisher
Springer Science and Business Media LLC
Reference21 articles.
1. Asakura, T., Takahashi, N., Takada, K., Inoue, T. & Ohkawa, K. (1997a). Drug conjugate of doxorubicin with glutathione is a potent reverser of multidrug resistance in rat hepatoma cells. Anti-Cancer Drugs 8: 199–203.
2. Asakura, T., Ohkawa, K., Takahashi, N., Takada, K., Inoue, T. & Yokoyama, S. (1997b). Glutathione-doxorubicin conjugate expresses potent cytotoxicity by a suppression of glutathione S-transferase activity: comparison between doxorubicin-sensitive and -resistant rat hepatoma cells. Br J Cancer 76: 1333–1337.
3. Bose, R., Verheij, M., Haimovits-Friedman, A., Scotto, K., Fuks, Z. & Kolesnick, R. (1995). Ceramide synthase mediates daunorubicin-induced apoptosis: an alternative mechanism for generating death signals. Cell 82: 405–414.
4. Chen, Z., Naito, M., Mashima, T. & Tsuruo, T. (1996). Activation of actin-cleavable interleukin 1-converting enzyme (ICE) family protease CPP-32 during chemotherapeutic agent-induced apoptosis in ovarian carcinoma cells. Cancer Res 56: 5224–5229.
5. Darmon, A. J., Nicholson, D. W. & Bleackley, R. C. (1995). Activation of the apoptotic protease CPP32 by cytotoxic T-cell-derived granzyme B. Nature 377: 446–448.
Cited by
23 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献